title: Reduced cardiac contractile responsiveness to isoproterenol in obese rabbits.
abstract: Although obesity is characterized by increased sympathetic nervous system activity, there is often a paradoxical reduction in cardiovascular end-organ response to sympathetic stimulation. Mechanisms involved in reduced sympathetic responsiveness in obesity have not been well characterized. Therefore, we determined cardiac contractile responsiveness to beta-stimulation in the obese rabbit model using both isolated heart (IH) and isolated papillary muscle (IPM) preparations. Female New Zealand White rabbits were fed control (IH: n=9; IPM: n=6) or 10% fat diets (IH: n=9; IPM: n=7) for 12 weeks. Contractile responsiveness in the IH was determined using a modified Langendorff preparation to evaluate the dose-response relationship between isoproterenol and 1) peak developed pressure/g of left ventricular wet weight and 2) maximal rate of pressure development (+dP/dt/P). Contractile responsiveness in the IPM was determined using right ventricular papillary muscles to evaluate the dose-response relationship between isoproterenol and (1) peak developed tension (T)/mm2 cross-sectional area (CSA) and (2) maximal rate of tension development (dT/dt/CSA). In the IH, baseline and maximum developed pressure/g were reduced in obese rabbits by 37% and 31%, respectively (P< or =.05). In the IPM, baseline and maximum T/CSA responses were reduced in obese rabbits by 59% and 33%, respectively (P< or =.05). Potency of isoproterenol as reflected by the EC50 did not differ between lean and obese animals in either preparation. These results demonstrate that left ventricular contractility in obesity is reduced at baseline and in response to stimulation with isoproterenol and suggest that decreased responsiveness to beta-stimulation may be a factor in the obesity-related systolic dysfunction.
authors.affiliation: Department of Physiology and Biophysics, University of Mississippi Medical Center, Jackson 39216-4505, USA.
authors.forename: J F
authors.initials: JF
authors.lastname: Carroll
authors.forename: A E
authors.initials: AE
authors.lastname: Jones
authors.forename: R L
authors.initials: RL
authors.lastname: Hester
authors.forename: G A
authors.initials: GA
authors.lastname: Reinhart
authors.forename: K
authors.initials: K
authors.lastname: Cockrell
authors.forename: H L
authors.initials: HL
authors.lastname: Mizelle
mesh_terms: D000818:Animals; D001794:Blood Pressure; D004305:Dose-Response Relationship, Drug; D005260:Female; D066298:In Vitro Techniques; D007545:Isoproterenol / Q000494:pharmacology*; D009200:Myocardial Contraction / Q000187:drug effects* / Q000502:physiology; D009765:Obesity / Q000503:physiopathology*; D009929:Organ Size; D010210:Papillary Muscles / Q000187:drug effects* / Q000502:physiology / Q000503:physiopathology; D011817:Rabbits; D012016:Reference Values; D016277:Ventricular Function, Left
chemical_list: D007545:Isoproterenol